Hematology analyzers (lease basis) to include reagents, consumables and maintenance

Ended Purchase Order Awarded Last action

Contract number
HT940824P0009
Awardee
Awarding agency
Obligated
$335,558

Award facts

Contract value 100% obligated
$335,557.92 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Brea, CA 92821, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00004 $27,688
Funding Only Action P00003 $110,751
Supplemental Agreement for work within scope P00002 $0
Funding Only Action P00001 · Hematology analyzers $197,119
Original award $0

About this award

The Defense Health Agency awarded a firm fixed-price purchase order to Beckman Coulter, Inc. for hematology analyzers on a lease basis, including reagents, consumables, and maintenance services. The contract, effective October 1, 2024, carries a ceiling value of $335,557.92 with an ultimate completion date of February 28, 2026. The place of performance is Brea, California, where Beckman Coulter maintains its headquarters. This procurement was conducted without set-aside designation, indicating open competitive procurement. Beckman Coulter, a subsidiary of Danaher Corporation, is an established provider of clinical laboratory diagnostic equipment and services to federal healthcare agencies, with extensive experience delivering automated laboratory instrumentation across multiple testing domains.

This award reflects the Defense Health Agency's ongoing commitment to modernizing its laboratory diagnostic capabilities across military medical facilities. Beckman Coulter maintains multiple existing indefinite delivery vehicles with the Defense Health Agency, including a $3.683 million IDIQ contract for specimen processing instrumentation and a $812,625 contract for urinalysis testing services, demonstrating the agency's confidence in the vendor's capabilities. The hematology analyzer lease arrangement provides the Defense Health Agency with access to advanced diagnostic technology while maintaining operational flexibility through the lease structure, allowing the agency to support clinical laboratory operations at military treatment centers nationwide.

Quick answers

Who was awarded contract HT940824P0009?

HT940824P0009 was awarded to Beckman Coulter, Inc. by Defense Health Agency (Department of Defense) on October 1, 2024.

How much is contract HT940824P0009 worth?

The government has obligated $335,558 on HT940824P0009.

Was contract HT940824P0009 competed?

The extent of competition for HT940824P0009 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award